Marty Makary
Tracked across 23 events · 1618 articles · First seen May 20, 2025 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Domestic
Impact: Marty Makary>>> resigned as Commissioner of the United States — Food and Drug Administration>>> after a tumultuous tenure marked by clashes with the Donald Trump>>> administration, industry, and public health groups. His departure creates uncertainty for several of his initiatives.
May 08, 2026 · 114 articles
Regulatory
Impact: As the Commissioner of the United States — Food and Drug Administration, Marty Makary is a key figure in implementing the new policy to reduce the number of required studies for drug approval, aiming to speed up drug development.
Feb 18, 2026 · 6 articles
Domestic
Impact: Marty Makary resigned as head of the United States — Food and Drug Administration, widening the leadership gap within the United States — United States Department of Health and Human Services and leaving behind unfinished initiatives.
May 13, 2026 · 6 articles
Regulatory
Impact: Marty Makary resigned as United States — Food and Drug Administration Commissioner, having engineered Tracy Beth Høeg's rapid rise and facing criticism from political allies.
May 15, 2026 · 17 articles
Domestic
President Donald Trump nominated Dr. Heidi Overton, a White House domestic policy aide, to lead the U.S. United States — Food and Drug Administration (FDA). Overton, a physician and deputy director of the White House…
Impact: Makary resigned as FDA commissioner in May after clashes with the White House. His departure created the vacancy Overton is nominated to fill.
Aug 19, 2026 · 101 articles
Domestic
Impact: Marty Makary, the United States — Food and Drug Administration Commissioner, announced the agency's actions regarding acetaminophen and leucovorin under the Trump administration's directive.
Sep 22, 2025 · 6 articles
Regulatory
Impact: As Food and Drug Commissioner, Marty Makary signaled the administration's stance on saturated fats and commented on protein guidance.
Jan 07, 2026 · 7 articles
Regulatory
On August 5, 2026, the U.S. United States — Food and Drug Administration (FDA) approved Moderna's mFLUSIVA (mRNA-1010), the first mRNA-based seasonal influenza vaccine, for adults aged 50 and older. The approval covers traditional approval…
Impact: Makary, former FDA Commissioner, faced criticism for vaccine scrutiny and resigned amid controversies.
Aug 05, 2026 · 105 articles
International
Impact: Marty Makary is resigning as the head of the United States — Food and Drug Administration due to difficulties and complaints from health industry executives, anti-abortion activists, and other Trump allies.
May 12, 2026 · 18 articles
International
Impact: Marty Makary resigned as the head of the United States — Food and Drug Administration after a rocky tenure and complaints from various industry groups.
Apr 16, 2026 · 760 articles
Domestic
Impact: Marty Makary, as United States — Food and Drug Administration Commissioner, announced steps to approve leucovorin as a treatment option for patients with low folate levels, potentially including some with autism.
Sep 22, 2025 · 6 articles
Regulatory
Impact: Former United States — Food and Drug Administration Commissioner Marty Makary had indicated that reviewing the benefits of MDMA and other psychedelics was a top priority, though his resignation may impact the pace of review.
May 26, 2026 · 6 articles
Regulatory
Impact: Former FDA chief who created the accelerated review pathway used for Lipfendra; resigned in May 2026.
Jul 16, 2026 · 93 articles
International
Impact: Marty Makary is resigning as the head of the United States — Food and Drug Administration after a rocky tenure, drawing complaints from various industry executives and activists.
Apr 30, 2026 · 116 articles
Business
Impact: FDA Commissioner Marty Makary, alongside Robert F. Kennedy Jr., announced steps to eliminate synthetic dyes, supporting the broader regulatory push for cleaner food ingredients.
Oct 01, 2025 · 7 articles
International
Impact: Marty Makary resigned as the United States — Food and Drug Administration Commissioner, contributing to the agency's leadership upheavals.
May 12, 2026 · 17 articles
Domestic
The U.S. Senate confirmed Dr. Erica Schwartz as the 22nd director of the United States — Centers for Disease Control and Prevention (CDC) in a 51-44 vote on August 5, 2026, ending nearly a year…
Impact: Makary's resignation as FDA commissioner contributed to the leadership vacuum in health agencies.
Jul 15, 2026 · 148 articles
Business
Impact: Marty Makary, former FDA commissioner, commented on the FDA's regulatory actions supporting psychedelic therapeutics.
Jul 16, 2026 · 25 articles
87
Marty Makary resignedTrump nominates Heidi...
40
United States — Food and Drug Administration forced resignations Marty MakaryFDA Approves Moderna's...
Kyle Diamantas
predecessor
↔
Marty Makary
Marty Makary led the FDA as commissioner with Kyle Diamantas serving as his depu
Kyle Diamantas
successor
↔
Marty Makary
Kyle Diamantas served as the FDA deputy commissioner under Marty Makary. Followi
United States — Food and Drug Administration
ex-commissioner
↔
Marty Makary
Marty Makary served as the Commissioner of the Food and Drug Administration for
+ 14 more relationships
View on Dashboard
ERGEN INTELLIGENCE
Track Marty Makary live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard